EBNA1 regulates cellular gene expression by binding cellular promoters

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 52, 2009, Pages 22421-22426

  Canaan, Allon ^a,b   Haviv, Izhak ^c   Urban, Alexander E ^a   Schulz, Vincent P ^a   Hartman, Steve ^a   Zhang, Zhengdong ^a   Palejev, Dean ^a   Deisseroth, Albert B ^d   Lacy, Jill ^b   Snyder, Michael ^a   Gerstein, Mark ^a   Weissman, Sherman M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; CD9 ANTIGEN; CENTROMERE PROTEIN E; CREB5 PROTEIN; CYCLIN D1; CYSTATIN C; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 3; EPITHELIAL MEMBRANE PROTEIN 3; EPSTEIN BARR VIRUS ANTIGEN 1; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTATHIONE TRANSFERASE P1; GTF2E2 PROTEIN; INTERFERON INDUCED PROTEIN 44 LIKE; INTERFERON STIMULATED PROTEIN 15; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 10; MYC PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NR3C2 PROTEIN; NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHACER IN B CELL 1; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEIN; RGS PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SERUM GLUCOCORTICOID REGULATED KINASE 1; TRISTETRAPROLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE EXPRESSION; HOST CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; VIRUS GENOME;

B-LYMPHOCYTES; BINDING SITES; CELL LINE; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

HUMAN HERPESVIRUS 4;

EID: 76049087454     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911676106     Document Type: Article

References (35)

1. Thompson MP, Kurzrock R (2004) Epstein - Barr virus and cancer. Clin Cancer Res 10:803-821.
2. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein - Barr virus. Nature Med 8:594-599.
3. Dalens M, Zech L, Klein G (1975) Origin of lymphoid lines established from mixed cultures of cord-blood lymphocytes and explants from infectious mononucleosis, Burkitt lymphoma and healthy donors. Int J Cancer 16:1008-1014.
4. Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47-56.
5. Kube D, et al. (1999) Expression of Epstein - Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J Virol 73:1630-1636.
6. Kaiser C, Laux G, Eick D, Jochner N,BornkammGW,KempkesB(1999)Theproto- oncogene c-myc is a direct target gene of Epstein - Barr virus nuclear antigen 2. J Virol 73:4481-4484.
7. Wilson JB, Bell JL, Levine AJ (1996) Expression of Epstein - Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15:3117-3126.
8. Nunez G, et al. (1989) Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc Natl Acad Sci USA 86:4589-4593.
9. Wood VH, et al. (2007) Epstein - Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 26:4135-4147.
10. Bornkamm,GW(2008) Epstein - Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers. Int J Cancer 124:1745-1755.
11. Shire K, Ceccarelli DF, Avolio-Hunter TM, Frappier L (1999) EBP2, a human protein that interacts with sequences of the Epstein - Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 73:2587-2595.
12. Middleton T, Sugden B (1994) Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein - Barr virus replication protein EBNA1. J Virol 68:4067-4071.
13. Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD (1990) Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein - Barr virus DNA. J Virol 64:2369-2379.
14. Rawlins DR, Milman G, Hayward SD, HaywardGS(1985) Sequence- specificDNAbinding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
15. Reisman D, Yates J, Sugden B (1985)Aputative origin of replication of plasmids derived from Epstein - Barr virus is composed of two cis-acting components. Mol Cell Bio 5:1822-1832.
16. Gahn TA, Sugden B (1995) An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein - Barr virus LMP gene. J Virol 69:2633-2636.
17. Reisman D, Sugden B (1986) trans activation of an Epstein - Barr viral transcriptional enhancer by the Epstein - Barr viral nuclear antigen 1. Mol Cell Bio 6:3838-3846.
18. Lee MA, Diamond ME, Yates JL (1999) Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein - Barr virus. J Virol 73:2974-2982.
19. Gregory CD, et al. (1991) Activation of Epstein - Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612-614.
20. Schena M, et al. (1992) Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981-2989.
21. Canaan A, Haviv I, Bowtell D, Lacy J (2002) The Tenth Biennial Conference of the International Association for Research on Epstein - Barr Virus and Associated Diseases. (Cairns, Australia).
22. Canaan A, Haviv I, Bowtell D, Lacy, J (2004) Sixth International Conference on Malignancies in AIDS and Other Immunodeficiencies: Basic, Epidemiologic and Clinical Research. (National Cancer Institute Bethesda, MD).
23. Canaan A, Urban EA, Weissman SM (2008) American Society for Microbiology: Manipulation of Nuclear Processes by DNA Viruses. (Charleston, SC).
24. O'Neil JD, et al. (2008) Epstein - Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 89:2833-2842.
25. Kong CF, Bowtell D (2002) Genomewide gene expression analysis using cDNA microarrays. Methods Mol Med 68:195-204.
26. Hartman SE, et al. (2005) Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 19:2953-2968.
27. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL (2001) Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein - Barr virus. Proc Natl Acad Sci USA 98:10085-10089.
28. Zhang ZD, et al. (2007) Tilescope: Online analysis pipeline for high-density tiling microarray data. Genome Biol 8:R81.
29. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297-3304.
30. Meraro D, Gleit-Kielmanowicz M, Hauser H, Levi BZ (2002) IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocytespecific transcription factors, PU. 1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: Characterization of a new subtype of IFN-stimulated response element. J Immunol 168:6224-6231.
31. Hieshima K, et al. (1997) A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol 159:1140-1149.
32. Celeste A, et al. (2002) Genomic instability in mice lacking histone H2AX. Science 296:922-927.
33. Hui AB, Lo KW, Teo PM, To KF, Huang DP (2002) Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 20:467-473.
34. Tachibana I, Hemler ME (1999) Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 146:893-904.
35. Dresang LR, Vereide DT, Sugden B (2009) Identifying sites bound by Epstein - Barr virus nuclear antigen 1 (EBNA1) in the human genome: Defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J Virol 83:2930-2940.